These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35477042)

  • 1. Anti-Müllerian hormone, an ovarian reserve marker in hypogonadotropic hypogonadism.
    Oncul M; Ozcivit IB; Basibuyuk Z; Cebi C; Sahmay S
    Eur J Obstet Gynecol Reprod Biol; 2022 Jun; 273():54-58. PubMed ID: 35477042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of Serum Anti-Mullerian Hormone in the Diagnosis of Ovarian Reserve Function in Patients with Premature Ovarian Insufficiency.
    Cai Y; Zhang Q; Yu K; Wang Q
    Biomed Res Int; 2022; 2022():3878359. PubMed ID: 36277874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of hypogonadotropic hypogonadism on ovarian reserve and response.
    Cecchino GN; Canillas GM; Cruz M; García-Velasco JA
    J Assist Reprod Genet; 2019 Nov; 36(11):2379-2384. PubMed ID: 31625035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pregnancy in a woman with idiopathic hypogonadotropic hypogonadism and low AMH: utility of ovarian reserve markers in IHH.
    Chan C; Liu K
    J Assist Reprod Genet; 2014 Oct; 31(10):1317-21. PubMed ID: 25113621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The status and comparison of ovarian reserve between fertile and infertile healthy Chinese women of reproductive age.
    Zhou SJ; Sun TC; Song LL; Yang M; Sun XP; Tian L
    Medicine (Baltimore); 2021 Apr; 100(17):e25361. PubMed ID: 33907092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discordance between serum anti-Müllerian hormone concentrations and antral follicle counts: not only technical issues.
    Alebic MŠ; Stojanovic N; Dewailly D
    Hum Reprod; 2018 Jun; 33(6):1141-1148. PubMed ID: 29688494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical value of serum anti-mullerian hormone and inhibin B in prediction of ovarian response in patients with polycystic ovary syndrome.
    Zhang F; Liu XL; Rong N; Huang XW
    J Huazhong Univ Sci Technolog Med Sci; 2017 Feb; 37(1):70-73. PubMed ID: 28224431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Müllerian Hormone and Ovarian Morphology in Women With Isolated Hypogonadotropic Hypogonadism/Kallmann Syndrome: Effects of Recombinant Human FSH.
    Bry-Gauillard H; Larrat-Ledoux F; Levaillant JM; Massin N; Maione L; Beau I; Binart N; Chanson P; Brailly-Tabard S; Hall JE; Young J
    J Clin Endocrinol Metab; 2017 Apr; 102(4):1102-1111. PubMed ID: 28324034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individualized FSH dosing based on ovarian reserve testing in women starting IVF/ICSI: a multicentre trial and cost-effectiveness analysis.
    van Tilborg TC; Oudshoorn SC; Eijkemans MJC; Mochtar MH; van Golde RJT; Hoek A; Kuchenbecker WKH; Fleischer K; de Bruin JP; Groen H; van Wely M; Lambalk CB; Laven JSE; Mol BWJ; Broekmans FJM; Torrance HL;
    Hum Reprod; 2017 Dec; 32(12):2485-2495. PubMed ID: 29121350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended LH administration as a strategy to increase the pool of recruitable antral follicles in hypothalamic amenorrhea: evidence from a case series.
    La Marca A; Longo M
    Hum Reprod; 2022 Oct; 37(11):2655-2661. PubMed ID: 36107111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The comparison of evaluative effectiveness between antral follicle count/age ratio and ovarian response prediction index for the ovarian reserve and response functions in infertile women.
    Zhou SJ; Zhao MJ; Li C; Su X
    Medicine (Baltimore); 2020 Sep; 99(36):e21979. PubMed ID: 32899038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between the serum luteinizing hormone to folliclestimulating hormone ratio and the anti-Müllerian hormone levels in normo-ovulatory women.
    Lee JE; Yoon SH; Kim HO; Min EG
    J Korean Med Sci; 2015 Mar; 30(3):296-300. PubMed ID: 25729253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infertile women below the age of 40 have similar anti-Müllerian hormone levels and antral follicle count compared with women of the same age with no history of infertility.
    Hvidman HW; Bentzen JG; Thuesen LL; Lauritsen MP; Forman JL; Loft A; Pinborg A; Nyboe Andersen A
    Hum Reprod; 2016 May; 31(5):1034-45. PubMed ID: 26965431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian luteinizing hormone priming preceding follicle-stimulating hormone stimulation: clinical and endocrine effects in women with long-term hypogonadotropic hypogonadism.
    Balasch J; Fábregues F; Carmona F; Casamitjana R; Tena-Sempere M
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2367-73. PubMed ID: 19366842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian reserve after treatment with alkylating agents during childhood.
    Thomas-Teinturier C; Allodji RS; Svetlova E; Frey MA; Oberlin O; Millischer AE; Epelboin S; Decanter C; Pacquement H; Tabone MD; Sudour-Bonnange H; Baruchel A; Lahlou N; De Vathaire F
    Hum Reprod; 2015 Jun; 30(6):1437-46. PubMed ID: 25801499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
    Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
    Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian reserve markers and endocrine profile during oral contraception: Is there a link between the degree of ovarian suppression and AMH?
    Landersoe SK; Larsen EC; Forman JL; Birch Petersen K; Kroman MS; Frederiksen H; Juul A; Nøhr B; Løssl K; Nielsen HS; Nyboe Andersen A
    Gynecol Endocrinol; 2020 Dec; 36(12):1090-1095. PubMed ID: 32362164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of anti-Mullerian hormone in predicting the response to clomiphene citrate in unexplained infertility.
    Coskun B; Dilbaz B; Karadag B; Coskun B; Tohma YA; Dur R; Akkurt MO
    Taiwan J Obstet Gynecol; 2018 Oct; 57(5):713-717. PubMed ID: 30342657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gonadotropin-releasing hormone agonist analog (nafarelin): a useful diagnostic agent for the distinction of constitutional growth delay from hypogonadotropic hypogonadism.
    Kletter GB; Rolfes-Curl A; Goodpasture JC; Solish SB; Scott L; Henzl MR; Beitins IZ
    J Pediatr Endocrinol Metab; 1996; 9(1):9-19. PubMed ID: 8887129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Mullerian Hormone as a Marker of Ovarian Reserve and Function.
    Sinha S; Sharan A; Sinha S
    Cureus; 2022 Sep; 14(9):e29214. PubMed ID: 36128562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.